Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded
- Contract number
- SPE2DB25FN3SH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,283
Award facts
- Contract value 100% obligated
- $12,282.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,282.72 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) with a firm fixed price and no set-aside designation. The award was made on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including military and veteran programs. The company was competitively selected for this delivery order, consistent with its track record of fulfilling diverse pharmaceutical procurement requirements for the Defense Logistics Agency. As a child contract under the broader IDC vehicle, this order represents a routine pharmaceutical supply fulfillment supporting the Defense Health Agency and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FN3SH?
SPE2DB25FN3SH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FN3SH worth?
The government has obligated $12,283 on SPE2DB25FN3SH.
Is contract SPE2DB25FN3SH an order under another contract?
Yes. SPE2DB25FN3SH is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3SH competed?
The extent of competition for SPE2DB25FN3SH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award